An icon in the shape of a lightning bolt. Impact Link Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert Bourla, Ph.D., outlined one potential response by his company if ...

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug ...

Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing ...

However, when Trump introduced some of the dignitaries in attendance, Pfizer chief Albert Boula was not well received. 'We also have the head of Pfizer here so I want to thank him, one of the ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the U.S., if required, as the Donald Trump administration threatens numerous ...

Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of Directors Pharmaceutical Research and Manufacturers of America (PhRMA) Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of ...

March 6 (Reuters) - Pfizer (PFE.N), opens new tab on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the development of its closely ...

The executive comes to Pfizer after wrapping up 10 years of service at Johnson & Johnson in October. Most recently, he served for two years as J&J's global therapeutic head of cardiovascular ...

Jasmine Laws is a Live News Reporter at Newsweek based in London, U.K. Her focus is reporting on health insurance, including Medicare and Medicaid, but she also writes about U.S. politics, crime ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC's Squawk on the Street ...